Dicot AB (publ) engages in the development of pharmaceutical products in Sweden. It is developing LIB-01 for the treatment of erectile dysfunction and premature ejaculation. The company was incorporated in 2015 and is based in Uppsala, Sweden.
Stock data | 2024 | Change |
---|---|---|
Price | $0.013370161876073754 | N/A |
Market Cap | $10.93M | N/A |
Shares Outstanding | 817.56M | N/A |
Employees | 2.00 | N/A |